Brendon Boot

Medicine · Health Sciences

16h-index2.4kcitations36works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Dementia and Cognitive Impairment Research(12), Parkinson's Disease Mechanisms and Treatments(8), Alzheimer's disease research and treatments(6), Ginkgo biloba and Cashew Applications(4), Functional Brain Connectivity Studies(3)

Publications36 total

Magnetic resonance imaging–guided phase 1 trial of putaminal <i>AADC</i> gene therapy for Parkinson's disease
Annals of Neurology·2019· 154 citedOpen Access
Anticholinergic Amnesia is Mediated by Alterations in Human Network Connectivity Architecture
Cerebral Cortex·2018· 15 citedOpen Access
Neuropsychiatric signs and symptoms of Alzheimer's disease: New treatment paradigms
Alzheimer s & Dementia Translational Research & Clinical Interventions·2017· 379 citedOpen Access
Prediction of cognition in Parkinson's disease with a clinical–genetic score: a longitudinal analysis of nine cohorts
The Lancet Neurology·2017· 181 citedOpen Access
Neuropathic Gaucher’s Mutations: Shifting Parkinson’s Into High Gear (S1.002)
Neurology·2017
Neuroenhancement: a call for better evidence on safety and efficacy
Oxford University Press eBooks·2017· 9 cited
Phenoconversion from probable rapid eye movement sleep behavior disorder to mild cognitive impairment to dementia in a population‐based sample
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring·2017· 9 citedOpen Access
Issue Information – Table of Contents
Annals of Neurology·2016Open Access
Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's
Annals of Neurology·2016· 268 citedOpen Access
Considering new treatment paradigms for neuropsychiatric symptoms of Alzheimer's disease
Alzheimer s & Dementia·2016· 2 cited
Temporal T807 binding correlates with CSF tau and phospho-tau in normal elderly
Neurology·2016· 99 citedOpen Access
P1‐040: Clinical Dementia Rating‐Sum of Boxes Responder Analysis in Prime: A Randomized Phase 1B Study of the Anti‐Amyloid Beta Monoclonal Antibody Aducanumab (BIIB037)
Alzheimer s & Dementia·2016· 1 citedOpen Access
O4‐01‐04: Entorhinal, parahippocampal, and inferior temporal F18‐T807 SUVR correlates with CSF total tau and tau T181P in cognitively normal elderly
Alzheimer s & Dementia·2015· 3 citedOpen Access
IC‐P‐162: Entorhinal, parahippocampal, and inferior temporal F18‐T807 SUVR correlates with CSF total tau and tau T181P in cognitively normal elderly
Alzheimer s & Dementia·2015· 2 citedOpen Access
Cerebral bleed after shunt for normal pressure hydrocephalus with cerebral amyloid angiopathy
Neurology Clinical Practice·2015· 3 citedOpen Access
Comprehensive treatment of dementia with Lewy bodies
Alzheimer s Research & Therapy·2015· 58 citedOpen Access
O3‐10‐06: AMYLOID‐β DEPOSITION IN MILD COGNITIVE IMPAIRMENT IS ASSOCIATED WITH HIPPOCAMPAL HYPERACTIVATION, ATROPHY, AND CLINICAL PROGRESSION
Alzheimer s & Dementia·2014· 1 cited
IC‐P‐117: AMYLOID‐B DEPOSITION IN MILD COGNITIVE IMPAIRMENT IS ASSOCIATED WITH HIPPOCAMPAL HYPERACTIVATION, ATROPHY, AND CLINICAL PROGRESSION
Alzheimer s & Dementia·2014· 1 citedOpen Access
Treatment of Dementia With Lewy Bodies
Current Treatment Options in Neurology·2013· 43 citedOpen Access
Daytime Sleepiness Is Associated with Decreased Default Mode Network Connectivity in Both Young and Cognitively Intact Elderly Subjects
SLEEP·2013· 62 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Jasmeer P. Chhatwal(9), Aaron P. Schultz(9), Bradley F. Boeve(8), Clemens R. Scherzer(8), Gad A. Marshall(7), Reisa A. Sperling(7), Tanis J. Ferman(6), Ronald C. Petersen(6), Roger A. Barker(6), Keith A. Johnson(6), David S. Knopman(5), Alexis Brice(5), Bernard Ravina(5), Johan Marinus(5), Eric McDade(5), Trey Hedden(5), Dorene M. Rentz(5), Ganqiang Liu(4), Joseph J. Locascio(4), Iris E. Jansen(4)